This collection will be made up of samples from individuals who are cognitively normal for age. They will undergo the following cognitive evaluations in order to exclude dementia: CogState, Groton Maze Learning Test and Mini Mental Status Exam.

In order to qualify for this collection, these normal subjects must have no history of neuropsychiatric disease and no family history of Alzheimer's disease.

PrecisionMed's sample bank is a repository of human blood, DNA, RNA, serum, plasma, CSF and other body fluid products linked to de-identified, audited, clinical data. Samples are available for sale to the pharmaceutical industry to enhance drug discovery and development, therapeutic target validation and molecular diagnostic product development. PrecisionMed provides customers access to samples with associated clinical information from a population of disease-specific subjects and healthy matched controls. PrecisionMed is rapidly expanding its collections to include additional neuropsychiatric and other diseases. PrecisionMed offers custom sample collections in any disease area, including non-psychiatric diseases.

PrecisionMed's samples are provided to our customers free of commercial incumbency and all samples are appropriately consented to permit all the types of potential uses noted above as well as others.

"We are pleased to add cerebrospinal fluid to our growing inventory of collections in the neuropsychiatric disease area," said John Flax MD., president and CEO of PrecisionMed. "Our current inventory includes banked collections in schizophrenia, Alzheimer's disease, major depression, cystic fibrosis, rheumatoid arthritis, bipolar disorder and we are adding controlled collections in mild cognitive impairment (MCI), Parkinson's disease and type II diabetes. PrecisionMed is skilled in performing custom collections and we have significant experience in accessing 'difficult to reach' populations. All these factors make PrecisionMed an attractive potential partner for research companies."

Subjects are enrolled into PrecisionMed collections based on strict inclusion criteria and clinical data is carefully audited before entry into the PrecisionMed database.

About PrecisionMed

PrecisionMed Inc., founded in 1994, is a privately held human biobank in the San Diego area. We collect, bank and market human genetic material, including proteins and metabolites linked to audited clinical phenotypic information. We cater to the pharmaceutical and biotechnology industries as well as certain academic institutions.